Alopecia following Treatment with Dextran Sulphate and Other Anticoagulant Drugs
- 3 May 1958
- Vol. 1 (5078) , 1034-1037
- https://doi.org/10.1136/bmj.1.5078.1034
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Dextran Sulphate: Use as an Anticoagulant, and Action in Lowering Serum CholesterolBMJ, 1956
- Duration of Anticoagulant Effect in Relation to Urinary Excretion of Dextran SulphateBMJ, 1956
- A Controlled Study of the Effect of Intermittent Heparin Therapy on the Course of Human Coronary AtherosclerosisCirculation, 1956
- The Anticoagulant Activity and Toxicity of Dextran Sulphate and a Xylan Polysulphuric AcidScandinavian Journal of Clinical and Laboratory Investigation, 1955
- THERAPEUTIC TRIAL OF THE SYNTHETIC HEPARIN ANALOGUE DEXTRAN SULPHATEThe Lancet, 1953
- An evaluation of anticoagulant therapyThe American Journal of Medicine, 1953
- THE BIOLOGICAL BEHAVIOUR OF A NEW SYNTHETIC ANTICOAGULANT (DEXTRAN SULPHATE) POSSESSING HEPARIN‐LIKE PROPERTIESBritish Journal of Pharmacology and Chemotherapy, 1952
- Dextran sulphate—a synthetic analogue of heparinBiochemical Journal, 1952
- Epilation in the Non-Irradiated Member of Parabiotically United Rats.Experimental Biology and Medicine, 1949
- Hyperheparinemia: Cause of the Hemorrhagic Syndrome Associated With Total Body Exposure to Ionizing RadiationScience, 1947